Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 74 Schemes (51.01%)
Foreign Institutions
Held by 92 Foreign Institutions (7.09%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
539 Million
(Quarterly Results - Dec 2025)
Net Profit:
36 Million
Pharmaceuticals & Biotechnology
USD 2,910 Million (Small Cap)
16.00
NA
0.00%
-79.90
-999,999.00%
0.00






